4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Lisata Therapeutics, Inc. (LSTA) operates in the Biotechnology industry and is headquartered in Basking Ridge, United States with about 21 employees. Its market capitalization is roughly $33 million. In the fiscal year ended 2025-12-31, LSTA reported $0M in revenue and ($17M) in net income.
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases.
Interactive charts & full statements → Open the LSTA valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $1M | $0M | $0M |
| Operating Income (EBIT) | ($18M) | ($22M) | ($26M) | ($58M) |
| Net Income | ($17M) | ($20M) | ($21M) | ($54M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($5M) | ($3M) | ($4M) | ($5M) | ($6M) |
| Net Income | ($4M) | ($3M) | ($4M) | ($5M) | ($5M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $18M | $35M | $55M | $73M | — |
| Total Liabilities | $3M | $6M | $7M | $7M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LSTA viewer.
About TickerBase · Data methodology & sources